FDA Inspection
RNA Bio/Pharma IncRNA Bio/Pharma Inc – FDA Inspection, May 24, 2013
Record Details
This FDA Inspection record concerns RNA Bio/Pharma Inc, with an inspection on May 24, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- RNA Bio/Pharma Inc
- Inspection Date
- May 24, 2013
- Product Type
- Drugs
View Company Profile
ID · 2761eafe-63ef-4139-ac28-4ccbb5ca4b39
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 834118
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.166(c)(1)Homeopathic drugs, assessment of stability
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RNA Bio/Pharma Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2025 | OAI | Seattle District Office | Drug Quality Assurance |
| June 25, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2017 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| October 31, 2008 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for RNA Bio/Pharma Inc
- FDA Inspection 1266530 - 2025-04-11
- FDA Inspection 1097487 - 2019-06-25
- FDA Inspection 1030091 - 2017-09-20
- FDA Inspection 546350 - 2008-10-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.